Public procurement notice: Contract Award Notice
Published: 2019-10-10
Buyer: NHS Supply Chain Operated by DHL Supply Chain Ltd acting as agent of Supply Chain Coordination Ltd (SCCL)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33140000: Medical consumables | 33141600 | 33194000
Estimated value: 32000000 EUR
Award criteria: The most economic tender

Technical requirements: NHS Supply Chain has established a non-exclusive framework agreement for supply to NHS Supply Chain depots via the stock/blue diamond routes and to the NHS Supply Chain customer base via the e-direct route.
The framework agreement is for the supply of wound drainage, post-operative and intra-operative autologous blood system products and consumables.
The framework agreement has an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months.
It is anticipated that in the first 24 months of the framework agreement the value of purchases will be circa 16 000 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 32 000 000 GBP. These values are approximate only and are based on the most recent historical usage information, with a forecasted level of growth. The values provided are for guidance only and are not a guarantee of business.
Wound drainage products are used in a medical environment to drain excess fluid from a wound to prevent infection and speed up the healing process. These are used post-surgery or after medical procedures and will aid in the healing process.
This lot includes, but is not limited to, wound drainage products such as low vacuum wound drainage systems, high vacuum wound drainage systems, passive/gravity wound drainage systems, silicon drains and wound drainage system accessories.
It is anticipated that in the first 24 months of the framework agreement the value of purchases for this lot will be circa 5 200 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 10 400 000 GBP.
The framework agreement will have an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months.
Post-operative autologous blood systems are used for the collection of blood from a single patient to be stored and then re-transfused at a later date. Typically the products are used procedures in advance of surgery which has high blood loss associated like joint replacements or spinal surgery.
This lot includes, but is not limited to, post-operative autologous blood system products such as post-operative auto transfusion kits and associated consumables, bottles, blood salvage systems and associated consumables/accessories.
It is anticipated that in the first 24 months of the framework agreement the value of purchases for this lot will be circa 1 800 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 3 600 000 GBP.
The framework agreement will have an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months.
Intra-Operative autologous blood systems are used to clean blood and recover red blood cells during surgery. Once the blood has been washed to remove unwanted blood components, the red blood cells are then reinfused.
This lot includes, but is not limited, intra-operative autologous blood system products such as bowls, processing sets, reinfusion bags, reservoirs, sequestration sets, suction lines, suction tubing, waste bags consumables and intra-operative autologous cell salvage blood machines
It is anticipated that in the first 24 months of the framework agreement the value of purchases for this lot will be circa 1 000 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 2 000 000 GBP.


Winner: Athrodax Healthcare International Ltd
Award value: 32000000
Number of bids: 11